查看购物车
  • Traditional Chinese
  • English
2021-2031 年北美医疗第二意见市场报告（范围、细分、动态和竞争分析）
市场调查报告书
商品编码
1843411

2021-2031 年北美医疗第二意见市场报告（范围、细分、动态和竞争分析）

North America Medical Second Opinion Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 105 Pages | 订单完成后即时交付

价格

北美医疗第二意见市场预计将大幅成长，到 2031 年将达到约 73.0696 亿美元，高于 2023 年的 24.8558 亿美元，在此期间的年复合成长率(CAGR) 为 14.4%。

执行摘要和市场分析

北美的医疗二次诊疗市场主要分为三个区域：美国、加拿大和墨西哥。该市场的成长得益于医疗二次诊疗服务日益普及以及医疗咨询领域持续的数位转型。此外，医疗体系的进步以及对改善治疗效果的日益重视预计将进一步推动市场成长。

市场区隔分析

北美医疗第二意见市场可以根据两个关键部分进行分析：医疗条件和服务提供者。

1. 依疾病状况：市场依各种医疗状况分类，包括癌症、骨科疾病、心臟疾病、神经系统疾病、肾臟疾病、血液系统疾病、慢性阻塞性肺病 (COPD)、器官移植等。值得注意的是，癌症领域在 2023 年占据了最大的市场。

2. 按服务提供者划分：市场也按服务提供者细分，包括医院、健康保险公司和线上服务。 2023年，医院占据了最大的市场。

市场展望

在全球范围内，由于医疗费用上涨，患者面临越来越大的经济压力，而医疗专业人员短缺和资源有限又加剧了这个问题。这种情况催生了对医疗成本优化的需求。由于患者希望避免不必要的手术和併发症，对第二医疗意见的需求日益增长。第二医疗意见服务为患者提供全面的信息，以便他们就治疗方案做出明智的决定。这些服务通常包括对病历的全面审查和替代治疗评估，从而可以降低医疗成本并改善患者预后。

研究表明，约有 31% 的患者在手术过程中会出现併发症，每年约有 420 万人在手术后死亡，这凸显了第二意见在降低手术相关风险方面的重要性。

国家洞察

北美医疗二次诊疗意见市场主要由美国推动，美国在2023年占据了最大的市场份额。癌症是美国第二大死亡原因，其发生率的上升为该市场带来了巨大的成长机会。 2022年，新增癌症病例超过190万例，导致约609,360人死亡。预计2024年将新增约200万例癌症病例，将进一步增加对二次诊疗意见的需求，尤其是在误诊普遍存在的情况下。

此外，美国医疗失误率极高，每年约有4,000起手术失误，7,000至9,000例死亡病例归因于用药错误。每年约有79.5万美国人因严重疾病被误诊，凸显了医疗保健系统中对第二诊疗意见的迫切需求。

为了应对这些挑战，像联合健康保险 (UnitedHealthcare) 这样的组织与 2nd.MD 等公司合作，为其会员提供免费的专家医疗意见服务。这项服务将患者与专家联繫起来，专家会审查他们的病例并提供第二意见。其他组织，例如 WorldCare International Inc.，也为重大疾病提供全面的第二意见服务，涵盖广泛的医疗状况。

公司简介

北美医疗第二意见市场的主要参与者包括 Second Opinion International、Elite Medical Services、The Cigna Group、Helsana、WorldCare、Vidal Health Insurance TPA Pvt Ltd、2nd.MD、Axa SA、Teladoc Health Inc、Included Health, Inc. 和 Royal Doctors。这些公司正在采用各种策略，包括市场扩张、产品创新和併购，以增强其产品服务并提升其市场占有率。

目录

第一章：简介

第二章：执行摘要

  • 关键见解
  • 市场吸引力

第三章：研究方法

  • 二次研究
  • 初步研究
    • 假设表述：
    • 宏观经济因素分析：
    • 显影基数：
    • 数据三角测量：
    • 国家级资料：

第四章：北美医疗第二意见市场－关键市场动态

  • 市场驱动因素
    • 越来越重视更好的治疗效果
    • 医疗成本优化的偏好日益增强
  • 市场限制
    • 新兴国家对第二医疗意见缺乏认识且不愿采纳
  • 市场机会
    • 远距医疗技术合作日益增多
  • 未来趋势
    • 医疗咨询服务数位化
  • 驱动因素和限制因素的影响：

第五章：北美医疗第二意见市场－市场分析

  • 2021-2031年北美医疗第二意见市场收入
  • 北美医疗第二意见市场预测分析

第六章：北美医疗第二意见市场分析－依条件

  • 癌症
  • 骨科疾病
  • 心臟疾病
  • 神经系统疾病
  • 肾臟疾病
  • 血液系统疾病
  • 慢性阻塞性肺病
  • 器官移植
  • 其他的

第七章：北美医疗第二意见市场分析－依服务供应商

  • 医院
  • 健康保险公司
  • 线上服务

第八章：北美医疗第二意见市场－国家分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥

第九章：产业格局

  • 概述
  • 市场倡议
  • 伙伴关係与合作

第十章：公司简介

  • Second Opinion International
  • Elite Medical Services
  • The Cigna Group
  • Helsana
  • WorldCare
  • Vidal Health Insurance TPA Pvt Ltd
  • 2nd.MD
  • Axa SA
  • Teladoc Health Inc
  • Included Health, Inc.
  • Royal Doctors

第 11 章：附录

Product Code: TIPRE00025159

The North America medical second opinion market is projected to grow significantly, reaching approximately USD 7,306.96 million by 2031, up from USD 2,485.58 million in 2023, with a compound annual growth rate (CAGR) of 14.4% during this period.

Executive Summary and Market Analysis

The medical second opinion market in North America is divided into three main regions: the United States, Canada, and Mexico. The growth of this market is driven by the increasing acceptance of medical second opinion services and the ongoing digital transformation in healthcare consulting. Additionally, advancements in healthcare systems and a heightened focus on improving treatment outcomes are expected to further propel market growth.

Market Segmentation Analysis

The North America medical second opinion market can be analyzed based on two key segments: medical conditions and service providers.

1. By Condition: The market is categorized into various medical conditions, including cancer, orthopedic disorders, cardiac disorders, neurological disorders, nephrological disorders, hematological disorders, chronic obstructive pulmonary disease (COPD), organ transplants, and others. Notably, the cancer segment accounted for the largest market share in 2023.

2. By Service Provider: The market is also segmented by service providers, which include hospitals, health insurance companies, and online services. In 2023, hospitals represented the largest share of the market.

Market Outlook

Globally, patients are facing increasing financial pressures due to rising healthcare costs, which are exacerbated by a shortage of healthcare professionals and limited resources. This situation has created a demand for healthcare cost optimization. The need for second medical opinions is growing as patients seek to avoid unnecessary surgeries and complications. Medical second opinion services provide patients with comprehensive information to make informed decisions regarding their treatment options. These services often involve a thorough review of medical records and alternative treatment assessments, which can lead to reduced healthcare costs and improved patient outcomes.

Research indicates that approximately 31% of patients experience complications from surgical procedures, and around 4.2 million postoperative deaths occur annually, highlighting the importance of second opinions in mitigating risks associated with surgery.

Country Insights

The North American medical second opinion market is primarily driven by the United States, which held the largest market share in 2023. The rising incidence of cancer, which is the second leading cause of death in the U.S., presents significant opportunities for growth in this market. In 2022, over 1.9 million new cancer cases were diagnosed, leading to approximately 609,360 deaths. Projections suggest that around 2 million new cancer cases will be diagnosed in 2024, further increasing the demand for second opinions, especially given the prevalence of misdiagnoses.

Moreover, the U.S. faces a high rate of medical errors, with around 4,000 surgical errors reported annually and 7,000 to 9,000 deaths attributed to medication errors. Approximately 795,000 Americans suffer from misdiagnoses of serious conditions each year, underscoring the critical need for second opinions in the healthcare system.

In response to these challenges, organizations like UnitedHealthcare have partnered with companies such as 2nd.MD to offer no-cost expert medical opinion services to their members. This service connects patients with specialists who review their cases and provide second opinions. Other organizations, such as WorldCare International Inc., also offer comprehensive second opinion services for critical illnesses, covering a wide range of medical conditions.

Company Profiles

Key players in the North America medical second opinion market include Second Opinion International, Elite Medical Services, The Cigna Group, Helsana, WorldCare, Vidal Health Insurance TPA Pvt Ltd, 2nd.MD, Axa SA, Teladoc Health Inc, Included Health, Inc., and Royal Doctors. These companies are employing various strategies, including market expansion, product innovation, and mergers and acquisitions, to enhance their offerings and increase their market presence.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macroeconomic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country-level data:

4. North America Medical Second Opinion Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Growing Emphasis on Better Treatment Outcomes
    • 4.1.2 Increasing Preference for Healthcare Cost Optimization
  • 4.2 Market Restraints
    • 4.2.1 Lack of Awareness and Reluctance Toward Adoption of Medical Second Opinion in Emerging Nations
  • 4.3 Market Opportunities
    • 4.3.1 Rising Collaborations in Telemedicine Technologies
  • 4.4 Future Trends
    • 4.4.1 Digitalization of Medical Consulting Services
  • 4.5 Impact of Drivers and Restraints:

5. North America Medical Second Opinion Market - Market Analysis

  • 5.1 North America Medical Second Opinion Market Revenue (US$ Million), 2021-2031
  • 5.2 North America Medical Second Opinion Market Forecast Analysis

6. North America Medical Second Opinion Market Analysis - by Condition

  • 6.1 Cancer
    • 6.1.1 Overview
    • 6.1.2 Cancer: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.2 Orthopedic Disorders
    • 6.2.1 Overview
    • 6.2.2 Orthopedic Disorders: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.3 Cardiac Disorders
    • 6.3.1 Overview
    • 6.3.2 Cardiac Disorders: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.4 Neurological Disorders
    • 6.4.1 Overview
    • 6.4.2 Neurological Disorders: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.5 Nephrological Disorders
    • 6.5.1 Overview
    • 6.5.2 Nephrological Disorders: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.6 Hematological Blood Disorders
    • 6.6.1 Overview
    • 6.6.2 Hematological Blood Disorders: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.7 COPD
    • 6.7.1 Overview
    • 6.7.2 COPD: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.8 Organ Transplant
    • 6.8.1 Overview
    • 6.8.2 Organ Transplant: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.9 Others
    • 6.9.1 Overview
    • 6.9.2 Others: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)

7. North America Medical Second Opinion Market Analysis - by Service Provider

  • 7.1 Hospitals
    • 7.1.1 Overview
    • 7.1.2 Hospitals: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Health Insurance Companies
    • 7.2.1 Overview
    • 7.2.2 Health Insurance Companies: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Online Services
    • 7.3.1 Overview
    • 7.3.2 Online Services: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. North America Medical Second Opinion Market - Country Analysis

  • 8.1 North America
    • 8.1.1 North America Medical Second Opinion Market Overview
    • 8.1.2 North America Medical Second Opinion Market - Revenue and Forecast Analysis - by Country
      • 8.1.2.1 North America Medical Second Opinion Market - Revenue and Forecast Analysis - by Country
      • 8.1.2.2 United States: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 8.1.2.2.1 United States: North America Medical Second Opinion Market Share - by Condition
        • 8.1.2.2.2 United States: North America Medical Second Opinion Market Share - by Service Provider
      • 8.1.2.3 Canada: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 8.1.2.3.1 Canada: North America Medical Second Opinion Market Share - by Condition
        • 8.1.2.3.2 Canada: North America Medical Second Opinion Market Share - by Service Provider
      • 8.1.2.4 Mexico: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 8.1.2.4.1 Mexico: North America Medical Second Opinion Market Share - by Condition
        • 8.1.2.4.2 Mexico: North America Medical Second Opinion Market Share - by Service Provider

9. Industry Landscape

  • 9.1 Overview
  • 9.2 Market Initiative
  • 9.3 Partnerships and Collaborations

10. Company Profiles

  • 10.1 Second Opinion International
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Products and Services
    • 10.1.4 Financial Overview
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 Elite Medical Services
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Products and Services
    • 10.2.4 Financial Overview
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 The Cigna Group
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Products and Services
    • 10.3.4 Financial Overview
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 Helsana
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Products and Services
    • 10.4.4 Financial Overview
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 WorldCare
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Products and Services
    • 10.5.4 Financial Overview
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments
  • 10.6 Vidal Health Insurance TPA Pvt Ltd
    • 10.6.1 Key Facts
    • 10.6.2 Business Description
    • 10.6.3 Products and Services
    • 10.6.4 Financial Overview
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Developments
  • 10.7 2nd.MD
    • 10.7.1 Key Facts
    • 10.7.2 Business Description
    • 10.7.3 Products and Services
    • 10.7.4 Financial Overview
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Developments
  • 10.8 Axa SA
    • 10.8.1 Key Facts
    • 10.8.2 Business Description
    • 10.8.3 Products and Services
    • 10.8.4 Financial Overview
    • 10.8.5 SWOT Analysis
    • 10.8.6 Key Developments
  • 10.9 Teladoc Health Inc
    • 10.9.1 Key Facts
    • 10.9.2 Business Description
    • 10.9.3 Products and Services
    • 10.9.4 Financial Overview
    • 10.9.5 SWOT Analysis
    • 10.9.6 Key Developments
  • 10.10 Included Health, Inc.
    • 10.10.1 Key Facts
    • 10.10.2 Business Description
    • 10.10.3 Products and Services
    • 10.10.4 Financial Overview
    • 10.10.5 SWOT Analysis
    • 10.10.6 Key Developments
  • 10.11 Royal Doctors
    • 10.11.1 Key Facts
    • 10.11.2 Business Description
    • 10.11.3 Products and Services
    • 10.11.4 Financial Overview
    • 10.11.5 SWOT Analysis
    • 10.11.6 Key Developments

11. Appendix

  • 11.1 About Us
  • 11.2 List of Abbreviations

List Of Tables

  • Table 1. North America Medical Second Opinion Market Segmentation
  • Table 2. North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Condition
  • Table 4. North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Service Provider
  • Table 5. North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 6. United States: North America Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Condition
  • Table 7. United States: North America Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Service Provider
  • Table 8. Canada: North America Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Condition
  • Table 9. Canada: North America Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Service Provider
  • Table 10. Mexico: North America Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Condition
  • Table 11. Mexico: North America Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Service Provider
  • Table 12. List of Abbreviations

List Of Figures

  • Figure 1. North America Medical Second Opinion Market Segmentation - Country
  • Figure 2. North America Medical Second Opinion Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America Medical Second Opinion Market Revenue (US$ Million), 2021-2031
  • Figure 5. North America Medical Second Opinion Market Share (%) - by Condition (2023 and 2031)
  • Figure 6. Cancer: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 7. Orthopedic Disorders: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Cardiac Disorders: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. Neurological Disorders: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Nephrological Disorders: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. Hematological Blood Disorders: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 12. COPD: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. Organ Transplant: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. Others: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 15. North America Medical Second Opinion Market Share (%) - by Service Provider (2023 and 2031)
  • Figure 16. Hospitals: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 17. Health Insurance Companies: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 18. Online Services: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. North America Medical Second Opinion Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 20. United States: North America Medical Second Opinion Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 21. Canada: North America Medical Second Opinion Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 22. Mexico: North America Medical Second Opinion Market - Revenue and Forecast, 2021- 2031 (US$ Million)